The challenge: Do pharmaceuticals present a risk to the environment, and what needs to be done to answer the question? by Sumpter, JP
ET& C Perspectives 
“Do pharmaceuticals present a risk to the environment and what needs to be done to 
answer the question?”  
John P Sumpter (Convener) 
“Although human pharmaceuticals are currently considered as emerging contaminants, 
many will have been present in the aquatic environment for decades. Two facts make the 
Pharmaceuticals in the Environment (PIE) issue of concern. One is that there are a few 
thousand different pharmaceuticals, and the other is that all of them are biologically active, at 
east in humans. These two facts lead us, in turn, to the two key unresolved issues in the PIE 
field: ‘how should we conduct a prioritisation exercise to identify those pharmaceuticals likely 
to be of the greatest environmental risk?’ and ‘are typical environmental concentrations of 
those pharmaceuticals anywhere close to the concentrations that produce adverse effects in 
ecotoxicity tests?’ This perspective addresses those two key issues.” 
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